Replies to post #38686 on Cel Sci Corporation (CVM)

[RobotDroid]

I am no spring chicken either, but this tells me that there are several paths to MK approval, even if we miss a few endpoints. But, I truly believe the 10% SOC will be handily beat. Just waiting for the news and Godot...

[Biobonic]

The issue or rather 2500 issues with AD

Clinical trials lists over 2500 trials for AD in the past.

With no effective treatments the mandated approach in years past was certainly not allowing the development of treatments.

The Obama Admin mandated a change to the approach in 2012 with a goal of treatment avail in 2025.

Some Links: national plan
biomarker focus
restaging


The fact that Aduhelm hasn't been shown to actually do much is beside the point, the point being an approved drug by 2025.

Classic bureaucratic operation.